# GeoVax Labs, Inc.: Form 8-K, filed Oct 27, 2026

- Company: [GeoVax Labs, Inc.](/companies/govx.md) (CIK 832489)
- Form: 8-K
- Filed: 2026-10-27
- Accepted by EDGAR: Oct 27, 2026, 09:00 ET
- Period: 2026-10-23
- Accession: 0001437749-26-033566
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/832489/000143774926033566/govx20261026_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/832489/000143774926033566/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 3.03: Change to security holders’ rights
- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/832489/000143774926033566/govx20261026_8k.htm

Filed Oct 27, 2026.
Source: SEC EDGAR, the filing index for accession 0001437749-26-033566. Last ingested by Listed: Nov 6, 2026, 17:14 ET. No prices; not investment advice.